Foundation Healthcare Plans to File Singapore IPO Prospectus Soon, Targeting Up to S$500 Million

What's Happening

Foundation Healthcare Holdings plans to file its IPO prospectus with the Singapore Exchange in the coming days, according to people with knowledge of the matter who spoke to Bloomberg. Both the Business Times and The Straits Times carried the report on June 15, 2026, drawing from that same Bloomberg sourcing.

After filing, the company aims to take investor orders for a listing that may close in the third quarter of 2026, the sources said. They asked not to be identified because the information is private.

The target raise is up to S$500 million. At that level, the IPO could value Foundation Healthcare at more than US$1 billion, according to the same sources.

Who Owns It

The company's largest institutional backer is SeaTown Holdings, the Singapore-based alternative asset manager with ties to Temasek. SeaTown put S$150 million into Foundation Healthcare in 2023, according to company filings cited by Bloomberg.

Other shareholders on the cap table include family office Blue7, Citrine Capital, property tycoon Kuik Ah Han's family, and Rizal Gozali, an Indonesia-based managing director at Jefferies Financial Group, per company filings.

Representatives for both Foundation Healthcare and SeaTown declined to comment when contacted.

Singapore's IPO Market Context

The timing matters. Singapore's IPO market has been building momentum in 2026, with five IPOs completed so far raising approximately US$912 million in aggregate, according to Bloomberg data. A single deal, UI Boustead REIT's debut, accounts for the lion's share of that total.

Foundation Healthcare, if it prices at the upper end, would rank among the largest Singapore listings of the year by a significant margin and could reset expectations for the market's capacity.

The Caveats Are Real

Both sources are careful to note that deliberations are ongoing and details may change. This is an anonymous-sourced preview of a filing that has NOT yet occurred as of June 15, 2026. No prospectus has been filed, no pricing range has been disclosed publicly, and no formal listing date has been set.

Anonymous-source IPO pre-announcements can move markets and investor sentiment before any verified information is on the public record. Retail investors reading headlines about a "US$1 billion valuation" should note that number comes from deal insiders with an interest in generating investor appetite, not from a filed prospectus with audited financials. Until Foundation Healthcare files publicly with the SGX, those figures are unverified.

The sourcing is Bloomberg, published simultaneously in two reputable Singapore financial outlets. The Straits Times and Business Times are both credible Singapore business publications, and neither presented the story as anything other than preliminary. Neither outlet fabricated a timeline or called this a done deal.

What Comes Next

The concrete next step is the prospectus filing itself. Once filed with the Monetary Authority of Singapore and publicly available on the SGX website, investors will have access to audited financials, disclosed risk factors, and the actual price range, none of which are available today.

The Parliament of Singapore passed legislation earlier this year allowing companies to list concurrently in Singapore and the United States, per The Straits Times. Whether Foundation Healthcare intends to pursue a dual listing has not been reported.

The key question is whether Foundation Healthcare's eventual prospectus will support the US$1 billion-plus valuation figure floated by deal insiders now, or whether audited numbers will tell a different story when they're public.